Company LumiraDx Limited

Equities

LMDXF

KYG5709L1095

Advanced Medical Equipment & Technology

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Quarterly earnings - Rate of surprise

Sector Other Advanced Medical Equipment & Technology

Market Closed - OTC Markets Other stock markets 01:26:20 27/04/2024 am IST			5-day change	1st Jan Change
0.017 ^USD	+10.68%		-15.00%	-72.97%

08/01	Top Midday Decliners	MT
08/01	LumiraDx Limited(OTCPK:LMDX.F) dropped from NASDAQ Composite Index	CI

LumiraDx Limited is a point of care diagnostic company. The Company is focused on transforming community-based healthcare by providing critical diagnostic information to healthcare providers at the point of need. The Company has developed and launched the LumiraDx Platform, which is an integrated system comprised of a small, versatile Instrument, low-cost microfluidic Test Strips, and seamless, secure digital connectivity. The Company offers a menu of lab comparable tests on a single portable platform, with more than 30 assays on the market and in various stages of development, covering infectious diseases, cardiovascular diseases, diabetes, and coagulation disorders. It also supports laboratory testing in an accessible high-throughput format to leverage molecular laboratory operations. Its diagnostic testing solutions are being deployed globally by governments and healthcare institutions across laboratories, urgent care, physician offices, pharmacies, schools and others.

Number of employees: 1,210

USD in Million	2021	Weight	2022	Weight	Delta
Medical Diagnostic Products 98.6 %	416	98.6 %	251	98.6 %	-39.61%
Platform Services 1.4 %	6	1.4 %	3	1.4 %	-40.01%

USD in Million	2021	Weight	2022	Weight	Delta
United States 54.8 %	251	59.5 %	140	54.8 %	-44.35%
Italy 19.3 %	66	15.6 %	49	19.3 %	-25.07%
United Kingdom 8.7 %	56	13.4 %	22	8.7 %	-60.45%
Other 7.8 %	1	0.1 %	20	7.8 %	+3,070.32%
Colombia 4.3 %	12	2.9 %	11	4.3 %	-9.52%
Germany 3.4 %	16	3.9 %	9	3.4 %	-46.88%
Sweden 1.5 %	7	1.7 %	4	1.5 %	-43.87%

Managers	Title	Age	Since
Ron Zwanziger CEO	Chief Executive Officer	70	01/14/01
Dave Scott FOU	Founder	67	01/14/01
Dorian LeBlanc DFI	Director of Finance/CFO	49	01/16/01
Thomas Quinlan PRN	Corporate Officer/Principal	61	01/17/01
Veronique Ameye LAW	General Counsel	47	01/15/01
Peter Welch PRN	Corporate Officer/Principal	-	-
David Walton PRN	Corporate Officer/Principal	70	01/14/01
Nigel Lindner PRN	Corporate Officer/Principal	67	01/14/01

Members of the board	Title	Age	Since
Dave Scott FOU	Founder	67	01/14/01
Ron Zwanziger CEO	Chief Executive Officer	70	01/14/01
Troyen Brennan BRD	Director/Board Member	69	01/16/01
Jerome McAleer FOU	Founder	68	01/14/01
Lok Chung Chan BRD	Director/Board Member	73	01/20/01
Donald Berwick BRD	Director/Board Member	77	01/18/01
Julia Lurene BRD	Director/Board Member	64	01/16/01
Bruce Keogh BRD	Director/Board Member	69	01/18/01
George Neble BRD	Director/Board Member	67	01/20/01
Lu Huang BRD	Director/Board Member	50	01/18/01

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	0	164,321,766	162,678,548 ( 99.00 %)	0	99.00 %

Name	Equities	%	Valuation
Ron Zwanziger 27.35 %	42,180,049	27.35 %	3 M $
Morningside Group Ltd. 17.81 %	27,464,978	17.81 %	2 M $
Bill & Melinda Gates Foundation 9.263 %	14,285,714	9.263 %	900 000 $
Bill Umphrey 8.512 %	13,128,350	8.512 %	827 086 $
Dave Scott 6.919 %	10,670,522	6.919 %	672 243 $
Senvest Management LLC 5.234 %	8,072,781	5.234 %	508 585 $
Senvest Management LLC 5.234 %	8,072,781	5.234 %	508 585 $
Jerome McAleer 5.017 %	7,736,677	5.017 %	487 411 $
Petrichor Healthcare Capital Management LP 3.671 %	5,660,848	3.671 %	356 633 $
Beacon Investment Advisory Services, Inc. 0.6712 %	1,035,100	0.6712 %	65 211 $

Name	Equities	%	Valuation
Ron Zwanziger 17.92 %	37,184,803	17.92 %	2 M $
Morningside Group Ltd. 11.71 %	24,296,120	11.71 %	2 M $
Dave Scott 5.143 %	10,670,522	5.143 %	672 243 $
Jerome McAleer 3.729 %	7,736,677	3.729 %	487 411 $
Anne M Umphrey 3.284 %	6,812,266	3.284 %	429 173 $
Senvest Management LLC 2.688 %	5,575,474	2.688 %	351 255 $
Bill & Melinda Gates Foundation Trust (Investment Management) 2.687 %	5,574,059	2.687 %	351 166 $
Bill Umphrey 2.585 %	5,363,256	2.585 %	337 885 $
Petrichor Healthcare Capital Management LP 1.540 %	3,195,284	1.540 %	201 303 $
David Walton 0.4348 %	902,122	0.4348 %	56 834 $

Name	Equities	%	Valuation
CVS HEALTH CORPORATION -	5,352,106	-	48 169 $
Morgan Stanley Capital Services LLC -	822,503	-	7 403 $
Goldman Sachs & Co. LLC -	215,680	-	1 941 $
LMR Partners LLP -	200,600	-	1 805 $
Balyasny Asset Management LP -	184,280	-	1 659 $
Kim LLC -	125,000	-	1 125 $
MMCAP International Inc. SPC -	42,976	-	387 $
Walleye Capital LLC -	30,000	-	270 $
Wolverine Asset Management LLC -	28,630	-	258 $
Covalent Partners LLC -	27,500	-	248 $

LumiraDX Ltd.

221 crescent Street 5th Floor

02543, Waltham

http://www.lumiradx.com

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Advanced Medical Equipment & Technology

Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
LUMIRADX LIMITED	-72.97%	6.1M
THERMO FISHER SCIENTIFIC	+8.07%	219B
DANAHER CORPORATION	+6.59%	183B
INTUITIVE SURGICAL, INC.	+11.26%	133B
BOSTON SCIENTIFIC CORPORATION	+26.57%	108B
EDWARDS LIFESCIENCES CORPORATION	+13.35%	52.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-0.62%	48.2B
AGILENT TECHNOLOGIES, INC.	-0.93%	40.37B
GE HEALTHCARE TECHNOLOGIES INC.	+11.54%	39.35B
RESMED, INC.	+26.76%	32.03B

Other Advanced Medical Equipment & Technology